contact us jpkrencn

お知らせ

企業動向

あなたはここにいる:ホーム > お知らせ > 企業動向 > Medicilon assisted G...

Medicilon assisted Guangshengtang in consistency evaluation of the generic drug Lamivudine Tablets

著者:medicilon   アップロード:2020-06-10  閲読回数:

Lamivudine (Brand name: Heganding) comes in 100-mg tablets. It’s a treatment for chronic Heptitis B adult patients with ALT rising, active virus replicating and liver decompensation.

During the evaluation project, Medicilon’s CMC and management team utilized innovative technology and comprehensive understanding of related guidance and regulations to contribute to success of the consisteny evaluation with biowaiver.

上の:Convalife and Medicilon announced a strategic pact to jointly conduct preclinical research

下に:Medicilon received the “Most Improved in the Science and Technology” award